{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T16:20:31Z","timestamp":1759940431871},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12,19]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We report a case of a 64-year-old woman treated with meglumine antimoniate (Glucantime\u00ae). On day 20, she developed fever, a pruriginous skin rash and myalgia. The blood tests showed eosinophilia and hepatic cytolysis. The clinico-biological picture improved gradually and the symptoms disappeared 4 weeks after the drug withdrawal. Six weeks later, intradermal tests to Glucantime\u00ae were performed and were positive at 48 hour-reading. This clinical picture suggests DRESS induced by meglumine antimoniate. To the best of our knowledge, only one case of meglumine antimoniate-induced DRESS has been reported in the literature and we are the first to report a case confirmed by skin tests.<\/jats:p>","DOI":"10.1515\/ap-2018-0104","type":"journal-article","created":{"date-parts":[[2018,10,27]],"date-time":"2018-10-27T09:05:05Z","timestamp":1540631105000},"page":"845-847","source":"Crossref","is-referenced-by-count":2,"title":["Meglumine antimoniate-induced DRESS: original case with a positive skin test"],"prefix":"10.1007","volume":"63","author":[{"given":"Amel","family":"Chaabane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haifa Ben","family":"Romdhane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajer Ben","family":"Brahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia Ben","family":"Fredj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zohra","family":"Chadli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naceur A","family":"Boughattas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Chakroun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karim","family":"Aouam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/jdv.13726","article-title":"Allergic reactions to meglumine antimoniate while treating cutaneous leishmaniasis","volume":"31","year":"2017","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"ref71","first-page":"31","article-title":"Old world cutaneous leishmaniasis: diagnosis and treatment","volume":"7","year":"2013","journal-title":"Journal of Dermatological Case Reports"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1365-4632.2012.05460.x","article-title":"Adverse effects of intralesional meglumine antimoniate and its influence on clinical laboratory parameters in the treatment of cutaneous leishmaniasis","volume":"51","year":"2012","journal-title":"International Journal of Dermatology"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1365-4632.2012.05460.x","article-title":"Adverse effects of intralesional meglumine antimoniate and its influence on clinical laboratory parameters in the treatment of cutaneous leishmaniasis","volume":"51","year":"2012","journal-title":"International Journal of Dermatology"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/jdv.13726","article-title":"Allergic reactions to meglumine antimoniate while treating cutaneous leishmaniasis","volume":"31","year":"2017","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2133.2006.07704.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"156","year":"2007","journal-title":"The British Journal of Dermatology"},{"key":"ref171","first-page":"31","article-title":"Old world cutaneous leishmaniasis: diagnosis and treatment","volume":"7","year":"2013","journal-title":"Journal of Dermatological Case Reports"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1111\/all.12050","article-title":"Delayed allergic skin reactions due to intralesional meglumine antimoniate therapy for cutaneous leishmaniasis","volume":"67","year":"2012","journal-title":"Allergy"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJMoa1202657","article-title":"Topical paromomycin with or without gentamicin for cutaneous leishmaniasis","volume":"368","year":"2013","journal-title":"The New England Journal of Medicine"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2340\/00015555-1222","article-title":"Six-year retrospective review of drug reaction with eosinophilia and systemic. symptoms","volume":"92","year":"2012","journal-title":"Acta Dermato-Venereologica"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"939","DOI":"10.4269\/ajtmh.2009.80.939","article-title":"Case report: Drug hypersensitivity syndrome induced by meglumine antimoniate","volume":"80","year":"2009","journal-title":"The American Journal Of Tropical Medicine And Hygiene"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2133.2006.07704.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"156","year":"2007","journal-title":"The British Journal of Dermatology"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1111\/all.12050","article-title":"Delayed allergic skin reactions due to intralesional meglumine antimoniate therapy for cutaneous leishmaniasis","volume":"67","year":"2012","journal-title":"Allergy"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJMoa1202657","article-title":"Topical paromomycin with or without gentamicin for cutaneous leishmaniasis","volume":"368","year":"2013","journal-title":"The New England Journal of Medicine"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"939","DOI":"10.4269\/ajtmh.2009.80.939","article-title":"Case report: Drug hypersensitivity syndrome induced by meglumine antimoniate","volume":"80","year":"2009","journal-title":"The American Journal Of Tropical Medicine And Hygiene"},{"key":"ref01","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s11882-014-0442-8","article-title":"Skin testing and patch testing in non-IgE-mediated drug allergy","volume":"14","year":"2014","journal-title":"Current Allergy and Asthma Reports"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2340\/00015555-1222","article-title":"Six-year retrospective review of drug reaction with eosinophilia and systemic. symptoms","volume":"92","year":"2012","journal-title":"Acta Dermato-Venereologica"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s11882-014-0442-8","article-title":"Skin testing and patch testing in non-IgE-mediated drug allergy","volume":"14","year":"2014","journal-title":"Current Allergy and Asthma Reports"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","year":"1981","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","year":"1981","journal-title":"Clinical Pharmacology and Therapeutics"}],"container-title":["Acta Parasitologica"],"original-title":[],"link":[{"URL":"http:\/\/www.degruyter.com\/view\/j\/ap.2018.63.issue-4\/ap-2018-0104\/ap-2018-0104.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.degruyter.com\/view\/j\/ap.2018.63.issue-4\/ap-2018-0104\/ap-2018-0104.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T20:44:37Z","timestamp":1720730677000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.degruyter.com\/view\/j\/ap.2018.63.issue-4\/ap-2018-0104\/ap-2018-0104.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,19]]},"references-count":20,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.1515\/ap-2018-0104","relation":{},"ISSN":["1896-1851","1230-2821"],"issn-type":[{"value":"1896-1851","type":"electronic"},{"value":"1230-2821","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12,19]]}}}